DER AOK-BUNDESVERBAND FÜHRT IM NAMEN DER IN DER BEKANNTMACHUNG GENANNTEN AUFTRAGGEBERINNEN DAS VERGABEVERFAHREN DURCH. has floated a tender for Contract notice: Pharmaceutical products. The project location is Germany and the tender is closing on 28 Feb 2021. The tender notice number is 035320-2019, while the TOT Ref Number is 30077435. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country : Germany

Summary : Contract notice: Pharmaceutical products

Deadline : 28 Feb 2021

Other Information

Notice Type : Tender

TOT Ref.No.: 30077435

Document Ref. No. : 035320-2019

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Purchaser : DER AOK-BUNDESVERBAND FÜHRT IM NAMEN DER IN DER BEKANNTMACHUNG GENANNTEN AUFTRAGGEBERINNEN DAS VERGABEVERFAHREN DURCH.
Office Name: Der AOK-Bundesverband führt im Namen der in der Bekanntmachung genannten Auftraggeberinnen das Vergabeverfahren durch.
Address: Rosenthaler Str. 31
Town: Berlin
Postal Code: 10178
Contact Point: Zentrale Vergabestelle



Germany
Email :vergabestelle@bv.aok.de
URL :www.aok.de

Tender Details

Object of the contract
Pharmaceutical products

Description: Contract notice: Pharmaceutical products

Authority Type: Body governed by public law
Contact Nature: Supplies
Procedure: Open procedure
Document: Contract notice
Regulation: European Union
Award criteria: Lowest price
CPV code: 33600000, 33600000, 33696000, 33696800, 33600000, 33696000, 33696800
CPV Description: Pharmaceutical products.

Reagents and contrast media.

X-ray contrast media.

Contrast media - Cross-drug open-house method for the KV region Rhineland-Palatinate / Saarland

Reference Number: 2019-01-21-RPS-PLO-Open -House

The subject of this publication is the conclusion of non-exclusive agreements on various contrast agent / drug combinations in the context of eggan open-house procedure, which is prescribed and paid by the health insurance funds in Rhineland-Palatinate and Saarland in the SSB. Details of the active substances concerned can be found in Annex 11 to this publication. Contrast media of each future contractor may be subject-specific during the contract period due to the economic efficiency offered by the contract doctorswho are informed of these economic sources of supply can be ordered; they are considered economical. Contract doctors are obliged to fulfill their demand for contrast agents from a specialist group in principle with the products of the contracting partner or one of the contractual partners. There is a fixed, non-negotiable contract price for each section. Designation: Notionic iodine-containing monomeric low-osmolar water-soluble nephrotropic X-ray contrast agents.

Application: Intra-arterial and intravenous and intracavitary. Other possible.

Areas of application:

- Urography,

- Computed tomography,

- angiography,

- digital subtraction angiography (DSA),

- angiocardiography, coronary arteriography, interventional coronary arteriography,

- fistulography, galacto



Active Ingredients / Combinations (ATC): Iohexol (V08AB02) and / or Iopamidol (V08AB04) and / or Iopromide (V08AB05) and / or Iomeprol (V08AB10) and / or Iobitridol (V08AB11) and / or Ioversol (V08AB07) and / or others possible.

Dosage Forms: All approved dosage forms of an active substance must be offered.

Concentration: 400 mg / ml.

Packing size: All authorized packag

Further information can be found in Annex 11 to the invitation to tender.

(1) Declaration for entry in the relevant trade or professional register in which the candidate / member of the applicant community is listed,

(2) Self-declaration that none of the exclusion reasons according to -- 123, 124 of the law against competition restrictions(1) Providing for uniform contract conditions and a single access procedure, all suitable and interested companies or communities of interested companies are offered the possibility of concluding a contract on the active substances / active substance combinations at any time. Interested companies can do this at the AOK Rheinland-Pfalz / Saarland the Vrequest earnings with prior signing of a confidentiality obligation (contact details e-mail address: am_vertraege@rps.aok.de). The other participation documents can be downloaded from the website www.dtvp.de if a form exists. A prerequisite for the conclusion of a contract is that the interested company completes the required documentscompleted and signed. Any company which fulfills the conditions of participation (see below) and who accepts the prescribed content of the contract (in each case depending on the subject group) and documents this by signing the declarations and the contract can sign up to the contract. An exclusivity is not given. The accession or the conclusion of the contract can beit and on the same conditions. Individual contract negotiations are not carried out; Uniform conditions apply. The given prices are to be accepted. The earliest date of the contract is 1.4.2019. On this basis, the contract duration is a maximum of 23 months. The contract ends at the latest on 28.2.2021, regardless of the date of the contract.

2) BeforeBackground of the until the expiration of the offer period on 28.2.2021 at any time possible submission (contract), it is to be understood that the date in 1.4.2.7) on 1.4.2019 (condition for the opening of temporally first possible offers) before the in IV.2.2) (deadline for the last possible submission of tenders)Publication is not an award of a public service contract within the meaning of the 2014/24 EU Procurement Coordination Directive of the European Parliament and of the Council or of the Public Procurement Law. In order to ensure the widest possible degree of transparency for the intended conclusion of the contract, it will be published in the Supplement to the Official Journal of the European Union. InIn the absence of a corresponding publication form, the contract notice will be used. The resulting conceptual requirements, such as the process name "open procedure", are solely due to the use of this announcement form and the publication platform.Another meaning, in particular a submission to public procurement rulesAs far as they do not follow directly from the TFEU and from the case law of the European Court of Justice on open house or approval models, this is not associated with it. All further information can be found in the participation and contract documents. An announcement of the assigned orders takes place exclusively on the website www.aok-gesundheitspartner.de

The closer to the order description resultsin each case from the available documents, in particular the invitation to tender and the terms of the contract.

Announcement ID: CXP4YDKYQ5R


Internet address (URL): www.aok.de

Documents

 Tender Notice